Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydreight Technologies Inc ( (TSE:NURS) ) just unveiled an announcement.
Hydreight Technologies Inc. reported a 33% year-over-year revenue growth for the first half of 2025 and achieved its third consecutive quarter of profitability. The company has focused on making its VSDHOne platform modular and has invested in strategic acquisitions to strengthen margins and accelerate growth. The company also launched a personalized genetic testing and wellness solution, expanded into new health verticals, and signed a strategic partnership with Perfect Scripts, LLC. These efforts position Hydreight to scale efficiently and achieve its 2025 objectives.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.00 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. operates as a mobile clinical network and medical platform, offering flexible at-home medical services across the United States. The company focuses on providing a modular platform, VSDHOne, which allows customers to adopt services tailored to their needs. Hydreight is involved in strategic investments and acquisitions to enhance its market presence and expand its service ecosystem.
Average Trading Volume: 337,843
Technical Sentiment Signal: Buy
Current Market Cap: C$80.28M
For detailed information about NURS stock, go to TipRanks’ Stock Analysis page.